FGFR4 Gly388Arg polymorphism contributes to prostate cancer development and progression: A meta-analysis of 2618 cases and 2305 controls

Overview of attention for article published in BMC Cancer, February 2011

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (72nd percentile)
Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

patent: 2 patents

Citations

dimensions_citation: 27 Dimensions

Readers on

mendeley: 27 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

MONOCLONAL ANTIBODY ANTI-FGFR4

Application WO-2019034427-A1

World Intellectual Property Organisation (WIPO)

MONOCLONAL ANTIBODY ANTI-FGFR4

Application EP-3444275-A1

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.